Asenapine


( Last Updated : December 12, 2011)
Generic Name:
Asenapine
Project Status:
Complete
Therapeutic Area:
Bipolar I disorder
Manufacturer:
Lundbeck Canada Inc.
Call for patient/clinician input open:
Brand Name:
Saphris
Project Line:
Reimbursement Review
Project Number:
SR0262-001
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Bipolar I disorder
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: